Related Experiment Video
Updated: Jul 20, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori and non-malignant diseases
Tamara Matysiak-Budnik1, Wiktor Laszewicz, Dominique Lamarque
1INSERM U793, Faculté de Médecine René Descartes, IFR94, Paris, France. matysiak@necker.fr
Helicobacter
|August 24, 2006
Summary
The prevalence of Helicobacter pylori (H. pylori)-associated ulcers is declining, but NSAID-induced ulcers are rising. H. pylori eradication may prevent NSAID complications and benefit some non-ulcer dyspepsia cases.
Area of Science:
- Gastroenterology
- Microbiology
Background:
- Peptic ulcer disease (PUD) epidemiology is shifting, with decreasing Helicobacter pylori (H. pylori)-associated ulcers and increasing NSAID-induced and H. pylori-negative idiopathic ulcers.
- The incidence of bleeding ulcers remains stable, but H. pylori virulence factors and host genetics are implicated in duodenal ulcer risk.
Purpose of the Study:
- To analyze the evolving landscape of peptic ulcer disease.
- To examine the role of H. pylori in PUD, NSAID complications, GERD, and dyspepsia.
Main Methods:
- Literature review and analysis of epidemiological trends in peptic ulcer disease.
- Examination of H. pylori virulence factors and host genetic associations with ulcer development.
- Assessment of H. pylori eradication impact on NSAID complications, GERD, and non-ulcer dyspepsia.
Main Results:
- H. pylori-associated ulcers are decreasing, while NSAID-induced and idiopathic ulcers are increasing.
- H. pylori eradication may prevent NSAID complications and is recommended before long-term PPI treatment in GERD patients to prevent gastric atrophy.
- A test-and-treat strategy for H. pylori in dyspepsia is more cost-effective than endoscopy.
Conclusions:
- The management of peptic ulcer disease requires adapting to changing etiological factors.
- H. pylori eradication strategies should be considered for specific patient groups, including those on NSAIDs or with dyspepsia, and in GERD patients prior to PPI therapy.
Related Concept Videos
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:25Peptic Ulcer Disease I: Introduction
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.